As reported by the National Cancer Institute, THC delta 8 binds to CB1 and CB2 receptors throughout the body. These receptors constitute the endocannabinoid system (ECS), a regulatory network that helps us maintain homeostasis, or total balance throughout the body. The affinity with the CB1 and CB2 receptors means that THC delta 8 has similar health benefits to those of delta 9, THC and CBD. However, delta 8 is different from CBD and delta 9 from THC in terms of its impact on cognition, perception and appetite stimulation. You can also use these cannabinoids in different proportions to achieve specific effects as part of the entourage effect.
If you're not a fan of the intense effect that can cause anxiety and paranoia, Delta 8 THC is a safer bet. Its potency has been measured between 50 and 70% of the potency of THC delta 9.Many users of delta 8 claim that the effect of this cannabinoid is less nervous and allows them to stay focused and relaxed. THC Delta 8 binds to CB1 receptors in the brain; these receptors play a key role in modulating the psychoactive experience of cannabis. Delta 8 has a lower affinity for CB1 receptors, hence its effectiveness in relieving anxiety and stress. When trying Delta 8 for THC, start at low levels and go slowly, taking 5 to 10 mg and waiting to see how it makes you feel.
Delta 8 has a late start compared to Delta 9; depending on how THC delta 8 is consumed, it can take 1 to 3 hours to take effect. Be sure to wait long enough before taking another dose to avoid side effects. Moderate and experienced users of delta 9 THC can take between 25 and 40 mg of delta 8 and use lower amounts for microdosing. A: 24 mg Delta 8 Gummies are equivalent to 10 mg of Delta 9 THC in marijuana gummies. Compared to THC, delta-8 THC appears to provide similar levels of relaxation and pain relief. While it seems to cause slightly lower levels of euphoria, it also seems to produce fewer cognitive distortions, such as an altered sense of time, problems with short-term memory and difficulty concentrating.
Participants were also much less likely to experience distressing mental states, such as anxiety and paranoia. Many participants commented that they could consume delta-8 THC and remain productive, while tending to use THC products recreational, due to their more potent and mind-altering effects. It is important for consumers to know that delta-8 products with THC have not been evaluated or approved by the FDA for safe use in any context. They can be marketed in ways that endanger public health and, especially, should be kept out of reach of children and pets. The FDA is aware of the growing concern surrounding delta-8 products with THC that are currently sold online and in stores.
These products have not been evaluated or approved by the FDA for safe use in any context. Some concerns include variability in product formulations and labeling, other cannabinoid and terpene contents, and varying concentrations of THC delta-8. In addition, some of these products may simply be labeled as “hemp products”, which may mislead consumers who associate “hemp” with “non-psychoactive products”. In addition, the FDA is concerned about the proliferation of products containing delta-8 THC and that are marketed for therapeutic or medical uses, even though they have not been approved by the FDA. Selling unapproved products with baseless therapeutic claims is not only a violation of federal law, but it can also put consumers at risk, since these products have not been proven to be safe or effective. This misleading marketing of unproven treatments poses significant public health problems, as patients and other users can use them instead of approved therapies to treat serious and even fatal illnesses.
Delta-8 THC has psychoactive and intoxicating effects, similar to delta-9 THC (i.e., marijuana). The FDA is aware of media reports on products containing THC delta-8 that they “place”. The FDA is also concerned that products with THC delta-8 may expose consumers to much higher levels of the substance than those found naturally in raw hemp and cannabis extracts. Therefore, the historical use of cannabis cannot be relied upon to establish a level of safety for these products in humans. The FDA is actively working with federal and state partners to further address concerns related to these products and to monitor the market for complaints about products, adverse events, and other emerging cannabis-derived products that may be a cause for concern.
The FDA will warn consumers about public health and safety issues and will take action when necessary when products regulated by the FDA violate the law. The American Association of Poison Control Centers (AAPCC) maintains the National Poison Data System (NPDS), which contains anonymous case records of self-reported information collected from callers during exposure control and informational calls about managed poisoning by the country's poison control centers (PCC). The NPDS data do not reflect the entire universe of exposures to a particular substance since additional exposures may not be reported to PCC; therefore, the NPDS data should not be interpreted as representing the full incidence of U. S. exposures. Exposures do not necessarily represent poisoning or overdose, and the AAPCC cannot fully verify the accuracy of each report.
The findings based on NPDS data do not necessarily reflect the views of the AAPCC. Delta 8 is believed to have analgesic and anti-inflammatory properties; therefore it can attack chronic inflammation and acute pain helping calm down inflammation and pain. In addition anecdotal evidence shows that Delta 8 may be effective in treating persistent headaches and muscle aches as well as inflammations and sores. Sign up for Consumer Update email notifications.
